AKT1 and familial pancreatic carcinoma: In summary, DDX23 knockdown could significantly suppress the malignant phenotypes of pancreatic cancer cells, in vivo tumor growth as well as lung metastasis in synergy with GEM treatment potentially by regulating PI3K/Akt signaling.